Press Release

Thirteen Hospitals Revolutionize Stroke Clinical Research

03.17.2014

Regional stroke trials network formed through funding from the National Institutes of Health

Palo Alto, California —Stroke is the leading cause of death in the United States. A stroke occurs when blood flow to the brain is interrupted, causing brain cells in the immediate area to die because they stop getting oxygen. Stroke can also occur when a vessel breaks and bleeds into the brain. To help advance stroke prevention, treatment and recovery, 13 medical centers have formed a Regional Stroke Trials Network. The National Institute of Neurological Disorders and Stroke (NINDS), will fund and manage the National Institutes of Health (NIH) Stroke Trials Network.

The network will share data and work together to help improve stroke care and outcomes for all patients. Participants in Stanford StrokeNet include:

  • California Pacific Medical Center, Newborn Intensive Care Unit
  • Community Hospital of the Monterey Peninsula
  • Dominican Hospital 
  • El Camino Hospital (including Los Gatos Acute Inpatient Rehabilitation)
  • Good Samaritan Hospital
  • Lucile Packard Children's Hospital Stanford
  • Mills-Peninsula Health Services
  • O'Connor Hospital
  • Oregon Health & Science University
  • Palo Alto Medical Foundation
  • Regional Medical Center of San Jose
  • Santa Clara Valley Medical Center
  • Stanford Hospital & Clinics

Together with 24 other regional networks, Stanford StrokeNet will conduct all major NIH funded clinical studies in stroke prevention, treatment and recovery. Each center will receive five-year funding, with $200,000 in research costs and $50,000 for training stroke clinical researchers per year over the first three years, and additional funds driven by the completion of milestones. Stanford Hospital & Clinics will lead the network as the Regional Coordinating Stroke Center, working closely with the other network participants on patient recruitment.

"This network will enable us to improve acute therapy and outcomes for stroke, while possibly discovering the most effective ways to prevent it," said Dr. Greg Albers, director of the Stanford Stroke Center and professor of neurology and neurological sciences at the Stanford University School of Medicine. "Together with the participating facilities, we have a tremendous opportunity to positively impact patient health by providing more patients with opportunities to participate in clinical trials."

Historically, the model for stroke clinical trials was to create large teams of personnel and infrastructure, which were then disassembled once the trial was completed. This led to delays in patient recruitment and additional costs when new trials were initiated, with some stroke clinical trials lasting many years longer than anticipated and costing millions of dollars more than the original estimates. This network will allow the most promising therapies to quickly advance to the clinic, to improve prevention, acute treatment, or rehabilitation of the stroke patient.

All participants in Stanford StrokeNet demonstrated experience in stroke research and recruitment, including the ability to enroll underrepresented populations, and are required to offer access to the full range of specialties that are involved in stroke care. These include: emergency medicine, neurosurgery, interventional neuroradiology, vascular neurology, neurointensive care, neuroimaging, stroke rehabilitation and pediatric neurology.

About National Institute of Neurological Disorders and Stroke (NINDS)

NINDS is the nation's leading funder of research on the brain and nervous system. The NINDS mission is to reduce the burden of neurological disease – a burden borne by every age group, by every segment of society, by people all over the world.

About the National Institutes of Health (NIH)

NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

About Stanford Health Care

Stanford Health Care (SHC) seeks to heal humanity through science and compassion one patient at a time, through its commitment to care, educate, and discover.  Across its health system of inpatient care, outpatient health centers, medical groups, health plan offerings, care navigation and virtual care services, Stanford Health Care provides patients with the very best in health and care through its unique leading edge and coordinated care approach.

Stanford Health Care is widely recognized for delivering the highest levels of care and compassion, while also discovering breakthroughs for treating cancer, heart disease, brain disorders, primary care issues, and many other conditions.  Stanford Health Care and its Stanford Hospital, along with Stanford Children’s Health and the Stanford University School of Medicine, are committed to delivering Stanford Medicine excellence to each and every patient and family served.

For more information, visit: www.stanfordhealthcare.org

Close